Target intelligence / Profile preview

Family with sequence similarity 3 member A (FAM3A)

Target
FAM3A
Molecular classification
Cytokine-like protein, Mitochondrial protein, Secreted signaling molecule, Other
01

Overview

Family with sequence similarity 3 member A (FAM3A) is a multifunctional cytokine-like and mitochondrial protein, secreted and implicated in the regulation of glucose and lipid metabolism, cellular energy homeostasis, and protection from cellular stress. FAM3A enhances mitochondrial ATP production and activates the ATP–P2 receptor–PI3K/Akt signaling pathway in metabolic organs, suppressing gluconeogenesis and lipogenesis and improving insulin sensitivity. It modulates angiogenesis and blood pressure in vascular cells, protects neurons from endoplasmic reticulum and oxidative stress, and supports insulin secretion in pancreatic beta cells. FAM3A expression is regulated by factors such as PPARγ and plays roles in various tissue types, offering therapeutic potential in metabolic, cardiovascular, and neurodegenerative diseases. There is no evidence for approved drugs or specific biomarkers directly targeting FAM3A as of the current literature. No significant safety or therapeutic challenges reported, but research is ongoing. The protein acts broadly in metabolism and stress, being a pleiotropic regulatory molecule rather than a classical receptor or enzyme.

Other names
Protein FAM3A2-19DXS560SXAP-7Cytokine-like protein 2-19DLDfamily with sequence similarity 3, member AFAM3A_HUMANFAM3 Metabolism Regulating Signaling Molecule A
02

Biological functions

Regulation of glucose metabolismRegulation of lipid metabolismCellular energy homeostasisCell survivalCellular differentiationAngiogenesisStress responseNeuroprotectionInsulin secretion regulationAdipogenesis
03

Disease associations

DiabetesNonalcoholic fatty liver diseaseCardiovascular disease (including blood pressure regulation, acute kidney injury)Neurodegenerative diseaseTissue regenerationDeafness (autosomal recessive 17)Ritscher-Schinzel syndrome 2
04

Safety considerations

No significant safety or therapeutic challenges reported, but research is ongoing.

Beyond the preview

Go deeper on Family with sequence similarity 3 member A (FAM3A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Family with sequence similarity 3 member A (FAM3A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call